BioNTech SE - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the BioNTech's COVID-19 vaccine program update call. (Operator Instructions) I must advise you that this call is being recorded today on Thursday, the 23rd of April 2020. I would now like to hand the call over to the Vice President, Investor Relations and Business Strategy, Sylke Maas. Please go ahead.
Thank you for joining us today for BioNTech's COVID-19 vaccine program update call. Before we start, I encourage you to view the slides for the webcast as well as the press release issued yesterday, April 22, both of which are accessible on our website in the Investors section.
As shown on Slide 2, during today's presentation, we will be making several forward-looking statements. These forward-looking statements include, but are not limited to, BioNTech's efforts to combat COVID-19; the planned next steps in BioNTech's Project Lightspeed; the timing to initiate clinical trials for BNT162 in Germany; collaborations between BioNTech and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
